Alexander L.T. Imholz

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 403 citations · Full text

Medicine, Prospective Safety Analysis, Cancer Management +9

The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients

Marja M. Pannekeet, Alexander L.T. Imholz, Dick G. Struijk et al. · Kidney International · 1995 · 195 citations

Capd Patients, Gastroenterology, Peritoneal Permeability Characteristics +3

Initial blood pressure fall on stand up and exercise explained by changes in total peripheral resistance

R. L. H. Sprangers, Karel H. Wesseling, Alexander L.T. Imholz et al. · Journal of Applied Physiology · 1991 · 180 citations

Upright Posture, Hypertension, Physical Activity +18

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 157 citations

Medicine, Clinical Trials, Gynecology +10

Appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent of CAPD

Désirée Zemel, Alexander L.T. Imholz, Dirk R. de Waart et al. · Kidney International · 1994 · 129 citations · Full text

Inflammation, Cytokine, Peritoneal Effluent +8